{
    "id": 28884,
    "fullName": "ESR1 - PCDH11X",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ESR1-PCDH11X results from the fusion of ESR1 and PCDH11X, which leads to estradiol-independent growth in cell culture, estradiol-independent enhanced gene expression, and increased cell motility (PMID: 30089255). ESR1-PCDH11X has been identified in estrogen-receptor positive breast cancer (PMID: 30089255).",
            "references": [
                {
                    "id": 12690,
                    "pubMedId": 30089255,
                    "title": "Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30089255"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2099,
        "geneSymbol": "ESR1",
        "terms": [
            "ESR1",
            "ER",
            "Era",
            "ESR",
            "ESRA",
            "ESTRR",
            "NR3A1"
        ]
    },
    "variant": "ESR1 - PCDH11X",
    "createDate": "10/29/2018",
    "updateDate": "10/31/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 27328,
                "geneSymbol": "PCDH11X",
                "terms": [
                    "PCDH11X",
                    "PCDH-X",
                    "PCDH-Y",
                    "PCDH11",
                    "PCDH11Y",
                    "PCDH22",
                    "PCDHX",
                    "PPP1R119"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 15146,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, estrogen-receptor positive breast cancer cells expressing ESR1-PCDH11X were resistant to Faslodex (fulvestrant) in culture (PMID: 30089255).",
            "molecularProfile": {
                "id": 30793,
                "profileName": "ESR1 - PCDH11X"
            },
            "therapy": {
                "id": 744,
                "therapyName": "Fulvestrant",
                "synonyms": null
            },
            "indication": {
                "id": 60075,
                "name": "estrogen-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12690,
                    "pubMedId": 30089255,
                    "title": "Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30089255"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15145,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Ibrance (palbociclib) resulted in growth inhibition of RB1-positive, estrogen-receptor positive breast cancer cells expressing ESR1-PCDH11X in culture (PMID: 30089255).",
            "molecularProfile": {
                "id": 30796,
                "profileName": "ESR1 - PCDH11X RB1 pos"
            },
            "therapy": {
                "id": 850,
                "therapyName": "Palbociclib",
                "synonyms": null
            },
            "indication": {
                "id": 60075,
                "name": "estrogen-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12690,
                    "pubMedId": 30089255,
                    "title": "Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30089255"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30793,
            "profileName": "ESR1 - PCDH11X",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30796,
            "profileName": "ESR1 - PCDH11X RB1 pos",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}